We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Hooker Furnishings Corp
HOFT
$159M
| $250K | ﹤0.01% |
+16,094
| New | +$274K |
|
1927
American Public Education
APEI
$869M
| $249K | ﹤0.01% |
+15,429
| New | +$263K |
|
1928
Tennant Co
TNC
$1.18B
| $248K | ﹤0.01% |
4,180
-106
| -2% | -$6.85K |
|
|
OLP
1929
One Liberty Properties
OLP
$512M
| $246K | ﹤0.01% |
9,456
+1,866
| +25% | +$51.7K |
|
1930
Anavex Life Sciences
AVXL
$314M
| $243K | ﹤0.01% |
24,302
-4,117
| -14% | -$39K |
|
1931
MVB Financial
MVBF
$387M
| $242K | ﹤0.01% |
7,790
+1
| +0% | +$38 |
|
1932
Spectrum Brands
SPB
$2.02B
| $242K | ﹤0.01% |
3,014
+16
| +0.5% | +$1.37K |
|
1933
Braskem
BAK
$889M
| $240K | ﹤0.01% |
16,796
+1,871
| +13% | +$32K |
|
1934
Expro Ltd
XPRO
$2.01B
| $240K | ﹤0.01% |
20,824
-2,480
| -11% | -$35.4K |
|
|
SPWR
1935
DELISTED
SunPower Corporation Common Stock
SPWR
| $240K | ﹤0.01% |
15,892
-144,546
| -90% | -$2.6M |
|
1936
The Greenbrier Companies
GBX
$1.43B
| $239K | ﹤0.01% |
6,646
+647
| +11% | +$27K |
|
1937
Helix Energy Solutions
HLX
$1.47B
| $239K | ﹤0.01% |
77,214
+40,704
| +111% | +$176K |
|
|
NPTN
1938
DELISTED
NEOPHOTONICS CORP
NPTN
| $238K | ﹤0.01% |
15,113
-5,031
| -25% | -$76.8K |
|
|
VRE
1939
DELISTED
Veris Residential
VRE
| $237K | ﹤0.01% |
18,028
-9,468
| -34% | -$146K |
|
|
WOW
1940
DELISTED
WideOpenWest
WOW
| $237K | ﹤0.01% |
13,024
-29,742
| -70% | -$598K |
|
1941
Kura Sushi USA
KRUS
$590M
| $235K | ﹤0.01% |
4,737
-95
| -2% | -$4.24K |
|
|
FMTX
1942
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $235K | ﹤0.01% |
+34,037
| New | +$239K |
|
|
VOXX
1943
DELISTED
VOXX International Corporation Class A
VOXX
| $234K | ﹤0.01% |
+25,154
| New | +$207K |
|
1944
CoreCivic
CXW
$3.26B
| $233K | ﹤0.01% |
20,997
+10,632
| +103% | +$128K |
|
1945
Arcosa
ACA
$7.11B
| $232K | ﹤0.01% |
5,006
-2,455
| -33% | -$129K |
|
1946
Accel Entertainment
ACEL
$978M
| $232K | ﹤0.01% |
+21,841
| New | +$244K |
|
1947
Aspen Aerogels
ASPN
$521M
| $232K | ﹤0.01% |
23,506
-10,628
| -31% | -$214K |
|
1948
Codexis
CDXS
$161M
| $232K | ﹤0.01% |
22,165
-45,948
| -67% | -$576K |
|
1949
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $231K | ﹤0.01% |
9,606
+1,650
| +21% | +$41.7K |
|
1950
Cooper-Standard Automotive
CPS
$504M
| $231K | ﹤0.01% |
+46,253
| New | +$270K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.